BioCentury
ARTICLE | Financial News

Rexahn raises $10 million

March 29, 2011 12:48 AM UTC

Rexahn Pharmaceuticals Inc. (NYSE-A:RNN) raised $10 million through the sale of 8.3 million units at $1.20 in a registered direct offering. Each unit comprises a share and a five-year warrant to purchase 0.4 shares, with each whole warrant exercisable at $1.50. Rodman was placement agent. ...